Cost-Containment Mechanisms for Essential Medicines, Including Antiretrovirals, in China - Health Economics and Drugs Series No. 013
(2003; 30 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentTerms of reference
Close this folderIntroduction
View the documentCost-effective medicine selection
View the documentPrice information
View the documentInternational open tendering
View the documentVoluntary discount agreements
View the documentVoluntary licensing
View the documentCompulsory licensing
View the documentLocal state production
View the documentGovernment price controls
View the documentReduction of import and other taxes for essential medicines, and rational dispensing practices
View the documentPublic investment in R & D for new medicines: A mid- to long-term strategy
View the documentBackground and experiences with voluntary agreements
View the documentCountry rights to be protected in voluntary agreements for reduction of prices of medicines
Open this folder and view contentsCompulsory licensing - practical aspects and procedures
View the documentConcluding comments
View the documentList of persons contacted
View the documentFurther reading
 

Cost-effective medicine selection

Selection of cost-effective medicines at the primary health care, hospital or national level should be a major, and probably the first, component of cost-containment of medicines in China. Selective medicines lists for public health systems or private insurance include:

• Positive lists (essential medicines) setting criteria for new medicines to qualify for reimbursement;

• Negative lists, as in some industrialized countries, which exclude medicines from coverage under the health insurance system for therapeutic or financial reasons.


From a macro-economic perspective, access to HIV-related medicines should be seen in the context of a consistent selection of medicines supplied to patients by the public sector or by health insurance schemes (see also page 9, Government price controls).

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014